DFCI-002-06

DFCI-002-06 is an orally active dual-target HCK/BTK PROTAC degrader with DC₅₀ values for HCK and BTK of 1.3 and 4.5 nM respectively. DFCI-002-06 retains higher anti-tumor activity than the HCK/BTK dual-target inhibitor (HY-15805), inducing apoptosis in cancer cells. DFCI-002-06 can be used for the study of MYD88 mutant B-cell malignancies.
(Pink: Src and Btk ligand (HY-15805); Blue: Cereblon ligand (HY-W087383); Black: linker).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • CAS. Nr.: 3092208-36-8
  • Formel: C44H46N10O5
  • Molecular Weight:794.90
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle PROTACs Isoform-spezifische Produkte anzeigen

More

Alle Src Isoform-spezifische Produkte anzeigen

More
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00